[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.171.146.16. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 768
Citations 0
Editorial
June 5, 2019

Is Interferon Therapy for Hepatitis C Infection a Treatable Risk Factor for Parkinson Disease?

Author Affiliations
  • 1Department of Neurology, Fixel Center for Neurological Diseases, University of Florida, Gainesville
  • 2Clinical and Translational Science Institute, Department of Medicine, University of Florida, Gainesville
JAMA Neurol. 2019;76(9):1006-1007. doi:10.1001/jamaneurol.2019.1377

Parkinson disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as bradykinesia, tremor, and gait and postural abnormalities as well as neuropsychiatric and other nonmotor symptoms. It is more common in older adults and increases in prevalence with age, although it can also affect younger individuals. Worldwide, approximately 7.5 million people are estimated to be living with PD, and by 2040 this number is expected to double over the next 2 decades.

×